Travere Therapeutics, Inc. TVTX
51.33 USD -0.66 (-1.27%)
Nov 11, 2026, 11:05 AM EST
51.00 Day range 52.19
22.59 52-week range 68.73
- YTD
- +34.34%
- 1 year
- +42.15%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 490.73M | 233.18M | 145.24M | 109.46M | 131.84M | |
| 490.73M | 233.18M | 145.24M | 109.46M | 131.84M | |
| 10.34M | 7.74M | 11.45M | 4.42M | 3.82M | |
| 480.39M | 225.43M | 133.79M | 105.04M | 128.02M | |
| 543.21M | 549.26M | 521.93M | 424.85M | 327.44M | |
| 206.01M | 217.50M | 244.99M | 227.33M | 201.16M | |
| 337.20M | 264.12M | 265.54M | 197.52M | 126.28M | |
| -62.82M | -323.83M | -388.14M | -319.81M | -199.43M | |
| 10.75M | 11.18M | 11.33M | 11.01M | 19.68M | |
| 988.00K | 120.00K | 223.00K | 313.00K | 409.00K | |
| -25.55M | -321.55M | -111.40M | -278.48M | -180.09M | |
| -25.55M | -321.55M | -111.40M | -278.48M | -180.09M | |
| -25.55M | -321.55M | -111.40M | -278.48M | -180.09M | |
| -25.55M | -321.55M | -111.40M | -278.48M | -180.09M | |
| -24.71M | 915.00K | -264.93M | -52.99M | -37.20M | |
| -0.29 | -4.08 | -1.50 | -4.37 | -3.01 | |
| -0.29 | -4.08 | -1.50 | -4.37 | -3.01 | |
| -0.29 | -4.08 | -1.50 | -4.37 | -3.01 | |
| -13.81M | -310.24M | -99.84M | -267.15M | -160.00M | |
| -13.81M | -310.24M | -99.84M | -267.15M | -160.00M | |
| 89.21M | 78.89M | 74.27M | 63.76M | 59.83M | |
| 89.21M | 78.89M | 74.27M | 63.76M | 59.83M |